Literature DB >> 19584560

TBK1-targeted suppression of TRIF-dependent signaling pathway of Toll-like receptors by 6-shogaol, an active component of ginger.

Se-Jeong Park1, Mi-Young Lee, Bu-Soon Son, Hyung-Sun Youn.   

Abstract

Toll-like receptors (TLRs) are primary sensors that detect a wide variety of microbial components involving induction of innate immune responses. After recognition of microbial components, TLRs trigger the activation of myeloid differential factor 88 (MyD88) and Toll-interleukin-1 (IL-1) receptor domain-containing adapter inducing interferon-beta (TRIF)-dependent downstream signaling pathways. 6-Shoagol, an active ingredient of ginger, inhibits the MyD88-dependent signaling pathway by inhibiting inhibitor-kappaB kinase activity. Inhibitor-kappaB kinase is a key kinase in nuclear factor kappaB (NF-kappaB) activation. However, it is not known whether 6-shogaol inhibits the TRIF-dependent signaling pathway. Our goal was to identify the molecular target of 6-shogaol in the TRIF-dependent pathway of TLRs. 6-Shogaol inhibited the activation of interferon-regulatory factor 3 (IRF3) induced by lipopolysaccharide (LPS) and by polyriboinosinic polyribocytidylic acid (poly[I:C]), overexpression of TRIF, TANK-binding kinase1 (TBK1), and IRF3. Furthermore, 6-shogaol inhibited TBK1 activity in vitro. Together, these results suggest that 6-shogaol inhibits the TRIF-dependent signaling pathway of TLRs by targeting TBK1, and, they imply that 6-shogaol can modulate TLR-derived immune/inflammatory target gene expression induced by microbial infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19584560     DOI: 10.1271/bbb.80738

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  11 in total

1.  Parthenolide inhibits TRIF-dependent signaling pathway of Toll-like receptors in RAW264.7 macrophages.

Authors:  Se-Jeong Park; Hwa-Jeong Shin; Hyung-Sun Youn
Journal:  Mol Cells       Date:  2011-01-18       Impact factor: 5.034

2.  6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-κB activation.

Authors:  H Ling; H Yang; S-H Tan; W-K Chui; E-H Chew
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

Review 3.  Ginger for Healthy Ageing: A Systematic Review on Current Evidence of Its Antioxidant, Anti-Inflammatory, and Anticancer Properties.

Authors:  Mehtap Ozkur; Necla Benlier; Işıl Takan; Christina Vasileiou; Alexandros G Georgakilas; Athanasia Pavlopoulou; Zafer Cetin; Eyup Ilker Saygili
Journal:  Oxid Med Cell Longev       Date:  2022-05-09       Impact factor: 7.310

4.  Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol.

Authors:  Ling Zhou; Lianwen Qi; Lifeng Jiang; Ping Zhou; Jiang Ma; Xiaojun Xu; Ping Li
Journal:  AAPS J       Date:  2014-01-15       Impact factor: 4.009

5.  Gingerol protects against experimental liver fibrosis in rats via suppression of pro-inflammatory and profibrogenic mediators.

Authors:  Mardi M Algandaby; Ali M El-Halawany; Hossam M Abdallah; Abdulrahman M Alahdal; Ayman A Nagy; Osama M Ashour; Ashraf B Abdel-Naim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-01-26       Impact factor: 3.000

6.  Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update.

Authors:  Francesco Peri; Valentina Calabrese
Journal:  J Med Chem       Date:  2013-11-20       Impact factor: 7.446

7.  Ginger compound [6]-shogaol and its cysteine-conjugated metabolite (M2) activate Nrf2 in colon epithelial cells in vitro and in vivo.

Authors:  Huadong Chen; Junsheng Fu; Hao Chen; Yuhui Hu; Dominique N Soroka; Justin R Prigge; Edward E Schmidt; Feng Yan; Michael B Major; Xiaoxin Chen; Shengmin Sang
Journal:  Chem Res Toxicol       Date:  2014-09-02       Impact factor: 3.739

Review 8.  The Cancer Prevention, Anti-Inflammatory and Anti-Oxidation of Bioactive Phytochemicals Targeting the TLR4 Signaling Pathway.

Authors:  Chung-Yi Chen; Chiu-Li Kao; Chi-Ming Liu
Journal:  Int J Mol Sci       Date:  2018-09-12       Impact factor: 5.923

Review 9.  Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway.

Authors:  Kurt Lucas; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-02-26       Impact factor: 5.590

10.  Screening of herbal extracts for TLR2- and TLR4-dependent anti-inflammatory effects.

Authors:  Anne Schink; Jan Neumann; Anna Lena Leifke; Kira Ziegler; Janine Fröhlich-Nowoisky; Christoph Cremer; Eckhard Thines; Bettina Weber; Ulrich Pöschl; Detlef Schuppan; Kurt Lucas
Journal:  PLoS One       Date:  2018-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.